CR20120133A - Composiciën de entrega de agente activo atrapado en carbohidrato y articulos que usan el mismo - Google Patents

Composiciën de entrega de agente activo atrapado en carbohidrato y articulos que usan el mismo

Info

Publication number
CR20120133A
CR20120133A CR20120133A CR20120133A CR20120133A CR 20120133 A CR20120133 A CR 20120133A CR 20120133 A CR20120133 A CR 20120133A CR 20120133 A CR20120133 A CR 20120133A CR 20120133 A CR20120133 A CR 20120133A
Authority
CR
Costa Rica
Prior art keywords
delivery
active agent
carbohydrate
composition
articles
Prior art date
Application number
CR20120133A
Other languages
English (en)
Inventor
Scott W Wenzel
David William Koenig
Jeffery Richard Seidling
Michael Meihan Chen
Original Assignee
Kimberly Clark Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kimberly Clark Co filed Critical Kimberly Clark Co
Publication of CR20120133A publication Critical patent/CR20120133A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Oncology (AREA)
  • Agronomy & Crop Science (AREA)
  • Communicable Diseases (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Lubricants (AREA)

Abstract

Están descritas aquí las composiciones de entrega y los sustratos para impartir un agente activo volátil a una superficie. Para lograr la entrega del componente volátil, una composición de entrega de una matriz de carbohidrato y un componente volátil son incorporados en la matriz de carbohidrato para estabilizar el volátil por períodos extendidos de tiempo.
CR20120133A 2009-10-13 2012-03-20 Composiciën de entrega de agente activo atrapado en carbohidrato y articulos que usan el mismo CR20120133A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/578,348 US20110086085A1 (en) 2009-10-13 2009-10-13 Carbohydrate Entrapped Active Agent Delivery Composition and Articles Using the Same

Publications (1)

Publication Number Publication Date
CR20120133A true CR20120133A (es) 2012-05-29

Family

ID=43855040

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20120133A CR20120133A (es) 2009-10-13 2012-03-20 Composiciën de entrega de agente activo atrapado en carbohidrato y articulos que usan el mismo

Country Status (10)

Country Link
US (2) US20110086085A1 (es)
EP (1) EP2488167A4 (es)
CN (1) CN102596187A (es)
BR (1) BR112012008504A2 (es)
CL (1) CL2012000737A1 (es)
CR (1) CR20120133A (es)
MX (1) MX2012003954A (es)
RU (1) RU2538689C2 (es)
WO (1) WO2011045681A2 (es)
ZA (1) ZA201201796B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8480852B2 (en) * 2009-11-20 2013-07-09 Kimberly-Clark Worldwide, Inc. Cooling substrates with hydrophilic containment layer and method of making
US9648874B2 (en) 2010-12-07 2017-05-16 Kimberly-Clark Worldwide, Inc. Natural, multiple use and re-use, user saturated wipes
US9832993B2 (en) 2010-12-07 2017-12-05 Kimberly-Clark Worldwide, Inc. Melt processed antimicrobial composition
US9149045B2 (en) 2010-12-07 2015-10-06 Kimberly-Clark Worldwide, Inc. Wipe coated with a botanical emulsion having antimicrobial properties
US10821085B2 (en) 2010-12-07 2020-11-03 Kimberly-Clark Worldwide, Inc. Wipe coated with a botanical composition having antimicrobial properties
US8445032B2 (en) 2010-12-07 2013-05-21 Kimberly-Clark Worldwide, Inc. Melt-blended protein composition
US8524264B2 (en) 2010-12-07 2013-09-03 Kimberly-Clark Worldwide, Inc. Protein stabilized antimicrobial composition formed by melt processing
JP2014506894A (ja) 2011-02-28 2014-03-20 テクノロジーズ・クロロス・インク 口腔吸収用の咀嚼可能なビヒクル
US8574628B2 (en) 2011-12-19 2013-11-05 Kimberly-Clark Worldwide, Inc. Natural, multiple release and re-use compositions
US10286095B2 (en) 2015-09-11 2019-05-14 Olson Ip Technologies, Inc. Travel kit
CN108951134A (zh) * 2017-05-19 2018-12-07 于凤 一种干巾的制作方法及干巾

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions
US5208038A (en) * 1989-12-08 1993-05-04 Dow Corning Corporation Coacervated highly absorptive polymers
US5124162A (en) * 1991-11-26 1992-06-23 Kraft General Foods, Inc. Spray-dried fixed flavorants in a carbohydrate substrate and process
AU6701694A (en) * 1993-04-16 1994-11-08 Mccormick & Company, Inc. Encapsulation compositions
JP5408684B2 (ja) * 1998-10-09 2014-02-05 ゼネラル ミルズ インコーポレイテッド 非連続な保存安定粒子を得るためにマトリックスに感受性液体成分を封入する方法
EP1059032A1 (en) * 1999-06-08 2000-12-13 The Procter & Gamble Company Disinfecting wet wipe
DE60023834T2 (de) * 1999-09-06 2006-08-10 Firmenich S.A. Verfahren zur herstellung von granulaten für die kontrollierte freigabe der flüchtigen verbindungen
US6716805B1 (en) * 1999-09-27 2004-04-06 The Procter & Gamble Company Hard surface cleaning compositions, premoistened wipes, methods of use, and articles comprising said compositions or wipes and instructions for use resulting in easier cleaning and maintenance, improved surface appearance and/or hygiene under stress conditions such as no-rinse
US6310014B1 (en) * 1999-10-05 2001-10-30 Phyzz Inc. Personal and household care compositions
US6576810B1 (en) * 2000-10-25 2003-06-10 Kimberly-Clark Worldwide, Inc. Toilet training article containing an effervescent agent
ATE290324T1 (de) * 2000-12-15 2005-03-15 Quest Int Eine feuchtigkeit- und sauerstoff-stabile zusammensetzung und verfahren zur herstellung
GB0102691D0 (en) * 2001-02-02 2001-03-21 Nestle Sa Water soluable powders and tablets
JP4394444B2 (ja) * 2001-10-24 2010-01-06 パワー ペーパー リミティド 活性物質の制御された皮膚内デリバリーのためのデバイス及び方法
JP2003137731A (ja) * 2001-11-02 2003-05-14 Naris Cosmetics Co Ltd 抗菌性粉体化粧料及び抗菌性粉体化粧料の製造方法
US20030224034A1 (en) * 2002-05-31 2003-12-04 Koenig David W. Personal care article and method for inhibiting attachment of yeast to skin
WO2008094877A2 (en) * 2007-01-30 2008-08-07 Drugtech Corporation Compositions for oral delivery of pharmaceuticals
NL2001320C2 (nl) * 2008-02-25 2009-08-26 Friesland Brands Bv Systeem voor aroma-afgifte.

Also Published As

Publication number Publication date
CL2012000737A1 (es) 2012-10-12
US20110086085A1 (en) 2011-04-14
MX2012003954A (es) 2012-05-22
RU2538689C2 (ru) 2015-01-10
RU2012119165A (ru) 2013-11-20
BR112012008504A2 (pt) 2019-09-24
WO2011045681A2 (en) 2011-04-21
EP2488167A2 (en) 2012-08-22
US20120263780A1 (en) 2012-10-18
CN102596187A (zh) 2012-07-18
WO2011045681A3 (en) 2011-07-14
ZA201201796B (en) 2013-05-29
EP2488167A4 (en) 2013-03-06

Similar Documents

Publication Publication Date Title
CR20120133A (es) Composiciën de entrega de agente activo atrapado en carbohidrato y articulos que usan el mismo
AR108936A2 (es) Formulación subcutánea de anticuerpo anti-her2
GT201400043A (es) Imidazopiridazinas sustituidas con amino
SV2008003071A (es) Composiciones farmaceuticas de antagonistas del anticuerpo anti-cd40
AR084057A1 (es) Composiciones para el cuidado de telas
CR20150523A (es) Uso de 2,3-dihidroimidazo [1,2-c]quinazolinas sustituidas
CL2014003509A1 (es) Composición veterinaria masticable blanda que comprende como agente activo un compuesto derivado de isoxazolina; y su uso para el tratamiento y/o prevención de una infestación y/o infección por parásitos en un animal (div. sol. n°2087-14).
CL2008002999A1 (es) Uso de una composicion farmeceutica que comprende trns-clominefo para preparar un medicamenteo util en el ratamiento de recuccion de los niveles de glucosa en ayunas en un varon.
CR20120090A (es) Formulaciones farmacéuticas muy concentradas
AR093386A1 (es) Composicion para tratar la diabetes o la diabesidad que comprende un analogo de oxintomodulina y metodo de tratamiento
CL2013001097A1 (es) Composicion farmaceutica oral que comprende 5-azacitidina, en donde la composicion libera la 5-azacitidina substancialmente en el estomago despues de su administracion, util para tratar una enfermedad asociada a la proliferacion anormal de celulas, tal como sindrome mielodisplasico y cancer ovarico (divisional de la solicitud 1170-09).
CL2013001982A1 (es) Metodo para reducir los niveles de glucosa y tratar trastornos del metabolismo de la misma; composicion farmaceutica que comprende metformina y otro agente antidiabetico o antiobesidad.
UY33598A (es) Imidazopiridazinas sustituidas
AR068195A1 (es) Composiciones y metodos para el tratamiento de semillas
AR068565A1 (es) Composiciones para el tratamiento del cabello
UY31780A (es) Fenoxibenzamidas sustituidas
CL2013002973A1 (es) Compuestos derivados de esteres de fenilglucopiranosil sustituidos mediadores del co-transportador sodio/d-glucosa (sglt); composicion farmaceutica; combinacion farmaceutica; y su uso en el tratamiento del sindrome metabolico, sindrome x, diabetes, resistencia a la insulina, entre otros
BR112012027080A2 (pt) composições orgânicas para tratar doenças relacionadas a beta - ena
CL2012003266A1 (es) Polisacarido de semillas de tamarindo para usarse en el tratamiento de infecciones microbianas; composicion farmacéutica y/o dermocosmética antimicrobiana que contiene dicho polisacárido; uso de un polisacárido de semilla de tamarindo ; metodo para tratar y/o prevenir a un paciente que tiene una infeccion microbiana.
AR101236A1 (es) Composiciones para el cuidado oral
AR075274A1 (es) Agente de tratamiento de semillas y metodo para proteger una planta
CR20110010A (es) Formulaciones que tienen una compatibilidad mejorada con sustratos no tejidos
AR091739A1 (es) Composiciones y metodos para reducir el riesgo cardiometabolico
CL2009001841A1 (es) Uso de una composición de liberación sostenida de 4-aminopiridina para preparar un medicamento útil para tratar esclerosis multiple en un sujeto.
AR086956A1 (es) Formulaciones liofilizadas de fgf-18